Brief: Kiniksa Pharmaceuticals Reports First Quarter 2022 Financial Results, Provides Corporate Update

Kiniksa Pharmaceuticals International

03/05/2022 13:43

May 3 (Reuters) - Kiniksa Pharmaceuticals Ltd  KNSA.O :
    * KINIKSA PHARMACEUTICALS REPORTS FIRST QUARTER 2022
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
    * KINIKSA PHARMACEUTICALS LTD - ARCALYST (RILONACEPT) NET
REVENUE
OF $22.2 MILLION IN Q1 2022
    * KINIKSA PHARMACEUTICALS LTD - ARCALYST FULL-YEAR 2022 NET
REVENUE EXPECTED TO BE $115 - $130 MILLION
    * KINIKSA PHARMACEUTICALS LTD - CASH RESERVES EXPECTED TO
FUND
OPERATIONS INTO AT LEAST 2024
    * KINIKSA PHARMACEUTICALS LTD - QTRLY NET LOSS PER SHARE
ATTRIBUTABLE TO COMMON SHAREHOLDERS -BASIC AND DILUTED $0.36

Source text for Eikon:  ID:nGNX6n0r8k 
Further company coverage:  KNSA.O